Print

Content - First Swiss Pavilion at Medtech fair in Tokyo

  • April 27, 2015

First Swiss Pavilion at Medtech fair in Tokyo

Tokyo (SCCIJ) - Switzerland has participated for the first time with a country pavilion at Medtec, Asia's largest trade-show dedicated to the design and manufacturing of medical devices. The participants of the Swiss Pavilion covered a broad spectrum ranging from universities, state-sponsored institutes, young startups and mature device manufacturers all looking for an entry into Japan's medical technology market. The Pavilion was organized by the Science & Technology Office of the Embassy of Switzerland in Japan. Here are the eight participants.

Swiss Pavilion at Medtech 2015

BioAlps Association

With a mission of promoting the excellence and performance in MedTech and BioTech developments in this cluster at all levels: regionally, nationally and in the international arena. BioAlps is the entry point to a wealth of contacts, knowledge. BioAlps organizes events and co-organizes conventions, participates in a number of international events and supports conferences promoting the cluster and offering its members a wealth of networking opportunities.  

Micronarc

Micronarc is the dedicated micro-nanotech cluster and communication platform created by the governments of the seven cantons that constitute Western Switzerland. Its primarily role is the development and promotion of the regional scientific, industrial and economic base in the sectors of micro and nanotechnology, as well as its educational structures, R&D facilities, technology transfer and inward investment.

Display case of electronic offering of Micro Systems Technologies at Swiss Pavilion, Medtech 2015 (click to enlarge)

Display case of electronic offering of Micro Systems Technologies at Swiss Pavilion, Medtech 2015 (click to enlarge)

Micro Systems Technologies

The Micro Systems Technologies group comprises four technology companies providing innovative products and services for medical devices, especially implants, and other high-reliability/high-performance industries. The offering includes HDI/microvia PCBs, ceramic substrates, electronic module design and manufacturing, advanced assembly and semiconductor packaging technologies, batteries and hermetic feedthroughs for implants.

CSEM

CSEM, founded in 1984, is a Swiss research and development center (public-private partnership) specializing in microtechnology, nanotechnology, microelectronics, system engineering, photovoltaics and communications technologies. CSEM is active in technology development from prototypes to small-series production and in technology transfer to industry worldwide. 450 highly qualified and specialized employees from various scientific and technical disciplines work for CSEM.

Prototype of the Nanolive cell tomograph at the Swiss Pavilion, Medtech 2015; actual production of device will start in July (click to enlarge)

Prototype of the Nanolive cell tomograph at the Swiss Pavilion, Medtech 2015; actual production of device will start in July (click to enlarge)

Nanolive

Nanolive has developed the 3D Cell Explorer thanks to a proprietary and completely innovative technology which overcomes the inherent limitations of light, and pushes it far beyond any physical limit ever thought possible. It combines holography with rotational scanning allowing the measurement of the refractive index distribution within the cell (3D) and during time (4D). Just like an MRI for human bodies, the product makes a complete tomography of the living cell. The result is quantitative cell tomography, in vitro without any invasion or sample preparation.  

EPFL - Bio-Nano Photonic Systems Laboratory

Bio-Nano Photonic Systems Laboratory (BIOS) in EPFL Bio-Engineering Department is pioneering on-chip optical nanobiosensors for new healthcare initiatives such as personalized medicine, early disease diagnostics, and for fundamental biology and pharmacology. BIOS's technologies use nano-scale photonics, nano/microfluidics and nanotechnology. BIOS recently introduced a hand-held, low-cost, sensitive and rapid diagnostic tool for point-of-care.

Robotic hand for rehabilitation purpose: Co-development by RELab of ETH Zurich and Mr. Jumpei Arata, Associate Professor, Center for Advanced Medical Innovation, University of Tokyo (click to enlarge)

Robotic hand for rehabilitation purpose: Co-development by RELab of ETH Zurich and Mr. Jumpei Arata, Associate Professor, Center for Advanced Medical Innovation, University of Tokyo (click to enlarge)

ETHZ - Rehabilitation Engineering Lab

The Rehabilitation Engineering Lab (ReLab) headed by Prof. Dr. Roger Gassert is part of the Institute of Robotics and Intelligent Systems of the ETH Zurich. The lab's research focuses on the development and clinical evaluation of diagnostic, therapeutic and assistive tools in order to promote recovery, independence and social integration of the physically disabled. Special interests are the hand function and how haptic feedback can benefit motor learning, rehabilitation therapy and human-machine-interaction.   

ETHZ - Functional Materials Laboratory

The Functional Materials Laboratory at ETH Zurich was founded in 2004 under the supervision of Prof. Stark. Main research areas are based on material science, particularly nano-safety, clinical and industrial applications of nanoparticles. At present, there have been over 170 publications, 20 patents and 6 spin-off companies. Due to this accumulated knowledge in material science, the FML has become a strong collaborator for the "Hochschulmedizin Zürich", a society that combines research from the University of Zurich, the University Hospital of Zurich and ETH Zurich.

Swiss Pavilion at Medtech 2015 with eight participants, Tokyo Big Sight (click to enlarge)

Swiss Pavilion at Medtech 2015 with eight participants, Tokyo Big Sight (click to enlarge)

Participating in Medtech 2016

Japan’s medical technology market, which is valued at approximately €21.5 billion, represents roughly 10% of the global market. It is the third largest medical device market in the world after the United States and the European Union. During the past 25 years, the size of Japan’s medtech market has doubled. While the market share of domestically made devices has been largely flat, imports have soared.  

As part of his initiative, Prime Minister Abe announced that he intends to launch a Japanese version of the NIH, further increasing the focus on the medical industry. 26 percent of Japan’s population is aged over 65 years – a world record! The Japanese society is not only aged but also wealthy and requests highest quality of health-care and medtech products and costly treatments: An ideal growth-market also for Swiss companies!  

If you are interested in being present at MEDTEC Japan 2016 as co-exhibitor of the Swiss Medtech Pavilion, or, if you require more information about MEDTEC Japan and Switzerland’s participation, please contact:

Dr. Matthias Frey
matthias.frey@eda.admin.ch
Tel: +81 3 5449 8400
Fax: +81 3 3473 6090
Embassy of Switzerland
Science & Technology Office Tokyo
Minami-Azabu 5-9-12,
Minato-ku, Tokyo 106-8589

 

Text: SCCIJ with material of STOT; Photos: SCCIJ

Our Sponsors

Platinum

Gold

Silver

Partner

Footer